PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Gastroenterologists generally trust and accept use of AI medical tools in clinics and hospitals, finds NTU Singapore study

2024-06-18
(Press-News.org)

Artificial intelligence (AI) has permeated many aspects of medicine, with promises of  accurate diagnoses, better management decisions, and improved outcomes for both patients and the healthcare system. However, to successfully implement AI technology in clinical practice, trust and acceptance among healthcare providers to use such tools is crucial.

Now, using the treatment of digestive diseases as a case study, an international study led by Nanyang Technological University, Singapore (NTU Singapore) has found that doctors in the gastroenterology practice generally trust and accept AI medical tools.

Through surveying 165 gastroenterologists and gastrointestinal surgeons in the Asia-Pacific region, the NTU Singapore-led research team found that eight in 10 say they accept and trust the use of AI-powered tools in diagnosing and assessing colorectal polyps (benign growths in the colon that could become cancerous).

When it came to using AI to guide an endoscopist on whether to remove polyps found in the bowel of those undergoing screening colonoscopy, seven in 10 said they accept and trust this AI-assisted application. (See Notes to Editor below for more data).

The research team found no difference in levels of acceptance between the male and female doctors, between those working in public and private settings, as well as between those working in big hospital units and small group practices.

However, the number of years of experience was a crucial factor. While one would expect young doctors to be more receptive to using technology in clinical decision making, the study found that  gastroenterologists with fewer than 10 years of clinical experience perceived a higher risk of these AI-powered medical tools than their colleagues with more than 10 years of experience.

The findings, published in the scientific journal JMIR AI in March, highlight the need for more research into what influences doctors’ acceptance of AI in their medical practice, said the team of scientists from Singapore, China, Hong Kong, and Taiwan.

Assistant Professor Wilson Goh from the NTU Lee Kong Chian School of Medicine (LKCMedicine), who led the study, said: “For this study, we zoomed in on the use of AI in the context of gastroenterology because we see that this specialty, with its heavy usage of image-based diagnosis and surgical or endoscopic intervention, will be able to readily use AI technologies in clinical management. This is one of the earliest reports of AI risk perception, acceptance, and trust among gastroenterologists, with a unique focus on the Asia-Pacific region.”

Asst Prof Goh, also the Co-Director of NTU’s Centre for Biomedical Informatics, said: “Although the study participants found certain AI technologies risky, most practitioners still trusted and accepted these applications, highlighting the intricate relationship between the complexity of AI technologies and their acceptance. AI has the potential to revolutionise the healthcare sector, but for AI to be integrated into the sector, a better understanding of the factors that underpin clinicians’ trust and acceptance towards AI-powered medical tools is necessary.”

NTU Senior Vice President (Health & Life Sciences) and Director of Centre for AI in Medicine Professor Joseph Sung, one of the study’s co-authors and a leading gastroenterologist, said: “The finding that more experienced gastroenterologists have a lower risk perception of AI tools is intriguing. Having more clinical experience in managing colorectal polyps among senior gastroenterologists may have given these clinicians greater confidence in their medical expertise and practice, thus generating more confidence in exercise clinical discretion when new technologies are introduced.”

 

On the other hand, a general lack of confidence when there is a discrepancy between AI and the human experience may be one of the reasons why less experienced doctors perceive AI as riskier when it involves invasive operative procedures such as removal of polyps in the colon, said Professor Sung, who is also the Dean of NTU’s LKCMedicine.

“A greater emphasis on AI, as we have implemented in NTU LKCMedicine’s recently refreshed curriculum, may help mitigate risk aversion and promote responsible AI use in clinical practice,” he added.

Professor May O. Lwin, Chair of the NTU Wee Kim Wee School of Communication, another study co-author whose research interest is in health communication, suggested that future studies could include patients’ perspective by assessing the circumstances in which patients would have concerns using AI technology in their health conditions.

She added: “It is important to capture the perspectives of other stakeholders, such as nurses, endoscopy assistants, and the general public, to understand better how their opinions align or conflict with each other. This will help us more realistically navigate complex trust and acceptance issues and create valuable propositions and effective policies.”

How the study was conducted

For this study, the scientists developed a questionnaire based on questions or statements adapted from validated frameworks and models.

Participants were asked to rate their level of agreement with the questions or statements designed to assess their level of trust, acceptance, and risk perception of AI use in gastroenterology.

Participants were also presented with three different medical scenarios in which AI could be applied:

For detection: to assist in identifying the presence of colorectal polyps and improving the detection rate of polyps that are likely to turn into cancer For characterisation: to assess the nature of pathology of polyps and predict the risk of a colorectal polyp turning cancerous For intervention: to guide the removal of polyps in an endoscopy

For each medical scenario, the participants were asked to rate their agreement with statements that assess their perceived risk and trust in AI tools, including :

I expect major risks involved with the AI diagnosis. I am ready to try the method myself.

They were also asked to rate their belief in statements that assess their acceptance of AI tools, such as:

Do you believe that machine learning algorithm can, in some cases (such as the ones described above), perform better than human beings?

The scores for each participant were then tabulated and used in statistical analyses to find out how the factors of risk perception, acceptance, and trust may interact with each other.

###

Data on gastroenterologists’ acceptance, trust

 

Acceptance

Trust

Detection of polyps

83.03%

85.45%

Characterisation of polyps

78.79%

85.45%

Surgical intervention to remove polyps

72.12%

72.12%

Full list of collaborators

NTU Singapore SingHealth National University Health System National University of Singapore Sun Yat-sen University Fourth Military Medical University Chinese University of Hong Kong National Taiwan University Hospital National Taiwan University Kaohsiung Medical University

***END***

END



ELSE PRESS RELEASES FROM THIS DATE:

State cannabis legalization and trends in cannabis-related disorders in older adults

2024-06-18
About The Study: Rates of cannabis-related disorder encounters increased from 2017 through 2022 among Medicare-insured older adults. This study observed the highest rates in states or territories that legalized adult and medical use of cannabis. The results also suggest higher average annual increases in states or territories that legalized medical cannabis. Corresponding author: To contact the corresponding author, Silvia Perez-Vilar, Ph.D., Pharm.D., email silvia.perezvilar@fda.hhs.gov To access the embargoed study: Visit our For The Media ...

Availability of medications for opioid use disorder in community mental health facilities

2024-06-18
About The Study: In this study of 450 community outpatient mental health treatment facilities in 20 high-burden states, approximately one-third offered medications for opioid use disorder (MOUD). These results suggest that further study is needed to report MOUD uptake, either through increased prescribing at all clinics or through effective referral models. Corresponding author: To contact the corresponding author, Jonathan Cantor, Ph.D., email jcantor@rand.org. To access the embargoed study: Visit our For The Media website at this link ...

Variation in postoperative outcomes across federally designated hospital star ratings

2024-06-18
About The Study: Although Centers for Medicare & Medicaid Services (CMS) hospital star rating was associated with postoperative mortality, serious complications, and readmissions, there was wide variation in surgical outcomes within each star rating group. These findings highlight the limitations of the CMS hospital star rating system as a measure of surgical quality and should be a call for continued improvement of publicly reported hospital grade measures.  Corresponding Author: To contact the corresponding author, Adrian Diaz, M.D., M.P.H., email adrian.diaz@osumc.edu. To access the embargoed ...

Sepsis patients could get the right treatment faster, based on their genes

2024-06-18
Sepsis patients could be treated based on their immune system’s response to infection, not their symptoms. New research uncovers how different people respond to sepsis based on their genetic makeup, which could help identify who would benefit from certain treatments and lead to the development of targeted therapies.   The team, from the Wellcome Sanger Institute, the University of Oxford, and collaborators, built on their previous work that identified different subgroups of patients with sepsis. They aimed to understand more about why sepsis response varies between patients and the different underlying immune response pathways. The new study, published today (18 June) in Cell Genomics, ...

Odors are encoded in rings in the brain of migratory locusts

Odors are encoded in rings in the brain of migratory locusts
2024-06-18
The migratory locust Locusta migratoria is an economically important crop pest that is said to have come to Egypt in the Old Testament as the eighth of the ten biblical plagues, "to devour all that plants that grow". The migratory locust is rarely found in Europe, but in Africa and Asia it not only causes millions of dollars’ worth of damage but also has a deadly impact on local people, threatening their food and their very existence. The locusts occur in two phases: as solitary animals and in swarms. The insects are most feared when they ...

New global research aims to improve survival rates for pancreatic cancer patients

2024-06-18
A new study published today in JAMA Network Open by an international cohort of researchers provides the latest data on the effectiveness of treating pancreatic cancer patients with chemotherapy (with or without radiation therapy) before surgery to remove a tumor. The study focuses specifically on pancreatic adenocarcinoma patients. The research found that after treatment and surgery, nearly five percent of patients had no detectable cancer cells left in the area where the tumor was, achieving a pathological complete response (pCR). “PCR means that the cancer has responded extremely well to the treatment, leaving no ...

Medication treatment for opioid use disorder offered at only a third of outpatient mental health facilities

2024-06-18
Only a third of outpatient community mental health treatment facilities in 20 states with the highest opioid related overdose deaths report offering medication treatment for opioid use disorders, suggesting efforts may be needed to strengthen such services, according to a new RAND study.   Among the 450 clinics surveyed, factors that increased the likelihood that clinics would provide medication for opioid use disorders included being a certified behavioral health clinic and providing integrated mental and substance use disorder treatment.   Researchers found that most clinics that did not offer medication treatment said they referred patients to other clinics for ...

Salk scientist Jesse Dixon named 2024 Pew Biomedical Scholar

Salk scientist Jesse Dixon named 2024 Pew Biomedical Scholar
2024-06-18
LA JOLLA (June 18, 2024)—Salk Institute Assistant Professor Jesse Dixon has been named a 2024 Pew Biomedical Scholar by The Pew Charitable Trusts. This honor provides funding to early-career investigators who demonstrate outstanding promise in science toward advancing human health. Dixon and the other 21 awardees will each receive $300,000 over four years to support their research. “Through his development and use of leading-edge genetic tools, Jesse has already made a major impact on how we study diseases such ...

Pew supports 22 researchers leading scientific innovation

2024-06-18
PHILADELPHIA—The Pew Charitable Trusts today announced the 22 researchers who have been selected to join the Pew Scholars Program in the Biomedical Sciences. These early-career scientists will receive four years of funding to explore some of the most pressing questions in human health and medicine. “Pew believes that supporting promising early-career researchers is key to scientific innovation, and for nearly 40 years our scholars have helped change the world—creating lifesaving therapies and responding to emerging health crises around the globe,” ...

Discovery of ‘new rules of the immune system’ could improve treatment of inflammatory diseases, say scientists.

Discovery of ‘new rules of the immune system’ could improve treatment of inflammatory diseases, say scientists.
2024-06-18
Scientists at the University of Cambridge have discovered that a type of white blood cell - called a regulatory T cell - exists as a single large population of cells that constantly move throughout the body looking for, and repairing, damaged tissue. This overturns the traditional thinking that regulatory T cells exist as multiple specialist populations that are restricted to specific parts of the body. The finding has implications for the treatment of many different diseases – because almost all diseases and injuries trigger the body’s immune system. Current anti-inflammatory drugs treat the whole ...

LAST 30 PRESS RELEASES:

Study unexpectedly finds living in rural, rather than urban environments in first five years of life could be a risk factor for developing type 1 diabetes

Editorial urges deeper focus on heart-lung interactions in pulmonary vascular disease

Five University of Tennessee faculty receive Fulbright Awards

5 advances to protect water sources, availability

OU Scholar awarded Fulbright for Soviet cinema research

Brain might become target of new type 1 diabetes treatments

‘Shore Wars:’ New research aims to resolve coastal conflict between oysters and mangroves, aiding restoration efforts

Why do symptoms linger in some people after an infection? A conversation on post-acute infection syndromes

Study reveals hidden drivers of asthma flare-ups in children

Physicists decode mysterious membrane behavior

New insights about brain receptor may pave way for next-gen mental health drugs

Melanoma ‘sat-nav’ discovery could help curb metastasis

When immune commanders misfire: new insights into rheumatoid arthritis inflammation

SFU researchers develop a new tool that brings blender-like lighting control to any photograph

Pups in tow, Yellowstone-area wolves trek long distances to stay near prey

AI breakthrough unlocks 'new' materials to replace lithium-ion batteries

Making molecules make sense: A regional explanation method reveals structure–property relationships

Partisan hostility, not just policy, drives U.S. protests

The Journal of Nuclear Medicine Ahead-of-Print Tip Sheet: August 1, 2025

Young human blood serum factors show potential to rejuvenate skin through bone marrow

Large language models reshape the future of task planning

Narrower coverage of MS drugs tied to higher relapse risk

Researchers harness AI-powered protein design to enhance T-cell based immunotherapies

Smartphone engagement during school hours among US youths

Online reviews of health care facilities

MS may begin far earlier than previously thought

New AI tool learns to read medical images with far less data

Announcing XPRIZE Healthspan as Tier 5 Sponsor of ARDD 2025

Announcing Immortal Dragons as Tier 4 Sponsor of ARDD 2025

Reporting guideline for chatbot health advice studies

[Press-News.org] Gastroenterologists generally trust and accept use of AI medical tools in clinics and hospitals, finds NTU Singapore study